X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Fulford India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs FULFORD INDIA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA FULFORD INDIA ABBOTT INDIA/
FULFORD INDIA
 
P/E (TTM) x 42.7 398.8 10.7% View Chart
P/BV x 10.7 6.2 171.6% View Chart
Dividend Yield % 0.6 0.1 743.4%  

Financials

 ABBOTT INDIA   FULFORD INDIA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
FULFORD INDIA
Mar-14
ABBOTT INDIA/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs6,015942 638.5%   
Low Rs3,707450 823.8%   
Sales per share (Unadj.) Rs1,236.9691.4 178.9%  
Earnings per share (Unadj.) Rs122.211.5 1,066.0%  
Cash flow per share (Unadj.) Rs129.015.4 839.7%  
Dividends per share (Unadj.) Rs35.002.00 1,750.0%  
Dividend yield (eoy) %0.70.3 250.6%  
Book value per share (Unadj.) Rs521.2380.0 137.2%  
Shares outstanding (eoy) m21.253.90 544.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.91.0 390.4%   
Avg P/E ratio x39.860.7 65.5%  
P/CF ratio (eoy) x37.745.3 83.2%  
Price / Book Value ratio x9.31.8 509.2%  
Dividend payout %28.617.4 164.2%   
Avg Mkt Cap Rs m103,2962,714 3,805.5%   
No. of employees `0003.00.4 665.8%   
Total wages/salary Rs m3,370505 667.3%   
Avg. sales/employee Rs Th8,891.86,073.0 146.4%   
Avg. wages/employee Rs Th1,140.01,137.4 100.2%   
Avg. net profit/employee Rs Th878.3100.7 872.4%   
INCOME DATA
Net Sales Rs m26,2842,696 974.8%  
Other income Rs m504125 402.2%   
Total revenues Rs m26,7892,822 949.3%   
Gross profit Rs m3,665-46 -7,899.6%  
Depreciation Rs m14415 950.0%   
Interest Rs m810 85.3%   
Profit before tax Rs m4,01754 7,398.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,42110 14,802.1%   
Profit after tax Rs m2,59645 5,808.3%  
Gross profit margin %13.9-1.7 -810.4%  
Effective tax rate %35.417.7 200.1%   
Net profit margin %9.91.7 595.9%  
BALANCE SHEET DATA
Current assets Rs m14,4461,738 831.1%   
Current liabilities Rs m4,725545 867.4%   
Net working cap to sales %37.044.3 83.6%  
Current ratio x3.13.2 95.8%  
Inventory Days Days5148 106.1%  
Debtors Days Days204 454.3%  
Net fixed assets Rs m1,11312 9,352.1%   
Share capital Rs m21339 544.9%   
"Free" reserves Rs m10,8081,443 749.0%   
Net worth Rs m11,0761,482 747.4%   
Long term debt Rs m00-   
Total assets Rs m16,2412,077 782.0%  
Interest coverage x497.06.7 7,399.9%   
Debt to equity ratio x00-  
Sales to assets ratio x1.61.3 124.6%   
Return on assets %16.02.6 614.4%  
Return on equity %23.43.0 777.1%  
Return on capital %36.34.3 844.2%  
Exports to sales %0.60-   
Imports to sales %12.624.5 51.7%   
Exports (fob) Rs m162NA-   
Imports (cif) Rs m3,322659 504.0%   
Fx inflow Rs m26817 1,558.1%   
Fx outflow Rs m3,927673 583.4%   
Net fx Rs m-3,659-656 557.9%   
CASH FLOW
From Operations Rs m2,51490 2,793.7%  
From Investments Rs m-800105 -764.3%  
From Financial Activity Rs m-803-14 5,694.3%  
Net Cashflow Rs m912181 505.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 75.0 100.0%  
Indian inst/Mut Fund % 7.9 3.8 207.9%  
FIIs % 0.1 0.1 100.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 21.2 80.7%  
Shareholders   18,270 4,783 382.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   NATCO PHARMA  PANACEA BIOTECH  CADILA HEALTHCARE  GSK PHARMA  PLETHICO PHARMA  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Losses; Capital Goods Sector Down 1.7%(11:30 am)

Indian share markets are presently trading on a negative note. Sectoral indices are trading in the red with stocks in the capital goods sector and metal sector witnessing maximum selling pressure.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Feb 19, 2018 01:41 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS